Company: HURA
Filing Date: 2025-05-23
Form Type: 424B3
Source: 0001193125-25-125499
Chunk: 25

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-23
Form: 424B3
Chunk 25
---
 2,315,387 shares of Kineta Common Stock with exercise prices ranging from $3.25 to $4.08 (the “Exchange”). Kineta has cancelled the Prior Warrants reacquired in the Exchange and such Prior Warrants will not be reissued. In addition, pursuant to the Exchange Agreement, in connection with the transactions contemplated by the Merger Agreement, the Holder agreed to (i) appear in person or online (for a virtual meeting) or by proxy at the Kineta special meeting and (ii) vote (or cause to be voted) the shares of Kineta Common Stock held by the Holder in favor of the approval of the Merger Agreement Proposal, the Compensation Proposal and the Kineta Adjournment Proposal. After giving effect to the Exchange, some of the 2023 Company Warrants remain outstanding.

| Q: | Will Kineta stockholders receive any portion of the proceeds from the Asset Sales? |

| A: | In connection with the Asset Sales, Kineta plans to distribute to Kineta stockholders cash, if any,        
 through the Disposed Asset Payment Right and pursuant to the terms and conditions of the Merger Agreement. |

| Q: | What will happen if, for any reason, either of the Mergers or the Asset Sales do not close? |

| A: | Neither the closing of the Mergers nor the closing of the Asset Sales is conditioned on the closing of                                                                                                                                                   
 the other. Therefore, if, for any reason, the Mergers do not close and the Merger Agreement is terminated, the Asset Sales can still close (subject to any conditions to closing contained in the Permitted Asset Disposition Agreement). Similarly, if, 
 for any reason, the Asset Sales do not close and the Permitted Asset Disposition Agreement is terminated, the Mergers can still close (subject to any conditions to closing contained in the Merger Agreement).                                          |

13

| $634,000. However, there can be no assurances as to the amount or timing of available cash, if any, left to distribute to stockholders after paying the debts and other obligations of Kineta and 
 setting aside funds for potential future claims, even if the Asset Sales close.                                                                                                                   |

| Q: | How does the TuHURA Board of Directors recommend that I vote at the TuHURA special meeting? |

| A: | The TuHURA Board of Directors unanimously recommends that you vote “FOR” the Authorized Share                                                                                        
 Increase Proposal, “FOR”